CN103713064B - 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 - Google Patents
一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 Download PDFInfo
- Publication number
- CN103713064B CN103713064B CN201410004760.XA CN201410004760A CN103713064B CN 103713064 B CN103713064 B CN 103713064B CN 201410004760 A CN201410004760 A CN 201410004760A CN 103713064 B CN103713064 B CN 103713064B
- Authority
- CN
- China
- Prior art keywords
- ecabet
- solution
- phosphate
- bismuth
- liquid chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IWCWQNVIUXZOMJ-MISYRCLQSA-N ecabet Chemical compound OC(=O)[C@@](C)([C@@H]1CC2)CCC[C@]1(C)C1=C2C=C(C(C)C)C(S(O)(=O)=O)=C1 IWCWQNVIUXZOMJ-MISYRCLQSA-N 0.000 title claims abstract description 47
- 229950003246 ecabet Drugs 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 30
- 239000000126 substance Substances 0.000 title claims abstract description 26
- 238000004128 high performance liquid chromatography Methods 0.000 title abstract description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 81
- 239000000243 solution Substances 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- NAYRZLVSOLIQSH-UHFFFAOYSA-N acetonitrile;methanol;phosphoric acid Chemical compound OC.CC#N.OP(O)(O)=O NAYRZLVSOLIQSH-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000945 filler Substances 0.000 claims abstract description 5
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000035945 sensitivity Effects 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims description 35
- 229910052797 bismuth Inorganic materials 0.000 claims description 33
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 23
- 238000004811 liquid chromatography Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 claims description 4
- 238000012937 correction Methods 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 235000019800 disodium phosphate Nutrition 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 8
- 239000012535 impurity Substances 0.000 abstract description 8
- 239000012085 test solution Substances 0.000 abstract 2
- 238000007865 diluting Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 239000000741 silica gel Substances 0.000 abstract 1
- 229910002027 silica gel Inorganic materials 0.000 abstract 1
- 239000012467 final product Substances 0.000 description 9
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000005286 illumination Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- YFSUTJLHUFNCNZ-UHFFFAOYSA-M 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YFSUTJLHUFNCNZ-UHFFFAOYSA-M 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- APBBAQCENVXUHL-UHFFFAOYSA-N n,n-diethylethanamine;2,2,2-trifluoroacetic acid Chemical compound CCN(CC)CC.OC(=O)C(F)(F)F APBBAQCENVXUHL-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- ROBLTDOHDSGGDT-UHFFFAOYSA-M sodium;pentane-1-sulfonate Chemical compound [Na+].CCCCCS([O-])(=O)=O ROBLTDOHDSGGDT-UHFFFAOYSA-M 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
相对保留时间 | 0.27 | 0.40 | 1.58 |
未破坏 | 0.0513 | 0.017 | —— |
酸破坏 | 1.8505 | 2.977 | —— |
碱破坏 | —— | —— | —— |
氧化破坏 | 0.1755 | 0.072 | —— |
高湿6天 | 0.1417 | 0.0227 | —— |
高温6天 | 0.1905 | 0.0279 | 0.0541 |
光照6天 | 0.240 | 0.0581 | 0.0609 |
供试品溶液浓度 | S/N | 进样量 | 定量限 |
0.466μg/ml | 10:1 | 10μl | 4.66ng |
供试品溶液浓度 | S/N | 进样量 | 检测限 |
0.186μg/ml | 3:1 | 10μl | 1.86ng |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410004760.XA CN103713064B (zh) | 2014-01-07 | 2014-01-07 | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410004760.XA CN103713064B (zh) | 2014-01-07 | 2014-01-07 | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103713064A CN103713064A (zh) | 2014-04-09 |
CN103713064B true CN103713064B (zh) | 2015-03-11 |
Family
ID=50406208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410004760.XA Active CN103713064B (zh) | 2014-01-07 | 2014-01-07 | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103713064B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104359991B (zh) * | 2014-11-21 | 2016-04-20 | 珠海亿邦制药股份有限公司 | 一种新的碱式依卡倍特铋有关物质的检测方法 |
CN107226804B (zh) * | 2016-03-25 | 2020-07-31 | 江苏奥赛康药业有限公司 | 一种右旋硫辛酸或其氨丁三醇盐的杂质和制备方法以及它们的检测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590031A (zh) * | 2008-06-17 | 2009-12-02 | 浙江爱生药业有限公司 | 磺化去氢松香酸二钠、其组合物及其应用 |
-
2014
- 2014-01-07 CN CN201410004760.XA patent/CN103713064B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590031A (zh) * | 2008-06-17 | 2009-12-02 | 浙江爱生药业有限公司 | 磺化去氢松香酸二钠、其组合物及其应用 |
Non-Patent Citations (4)
Title |
---|
Zhang, Dan;Du, Xiaolin;Liu, Mingyuan.Determination of ecabet in human plasma by high-performance liquid chromatography-tandem mass spectrometry.《JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES》.2008,第863卷(第2期),223-228. * |
刘广娟,裴志东,张镓小,张慧.HPLC 测定依卡倍特钠颗粒有关物质及其含量.《中国现代应用药学》.2012,第29卷(第1期),70-72. * |
王晶,丁黎,杜晓琅,唐立超,王永庆.人尿中磺化脱氢松香酸和铋的测定及尿药排泄特征研究.《中国药学杂志》.2012,第47卷(第10期),825-829. * |
高效液相色谱法测定碱式依卡倍特铋干混悬剂中有机酸根的含量;谢春;《海峡药学》;20101231;第22卷(第12期);方法与结果部分第2.1节和第2.2节 * |
Also Published As
Publication number | Publication date |
---|---|
CN103713064A (zh) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104237421B (zh) | 一种琥珀酸曲格列汀及其制剂的有关物质检测方法 | |
WO2018107975A1 (zh) | 一种右丙亚胺的分析方法 | |
CN103487518B (zh) | 注射用盐酸克林霉素杂质的检测方法及含量测定方法 | |
CN106556663A (zh) | 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪或其盐的检测方法 | |
CN103713064B (zh) | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 | |
CN107703230A (zh) | 一种盐酸溴己新有关物质的高效液相色谱检测法 | |
CN103728389B (zh) | 使用hplc法测定丁酸和丁酸钠的方法 | |
CN104535688B (zh) | 一种盐酸氨溴索缓释胶囊释放度的测定方法 | |
Pimenta et al. | Ofloxacin determination in urine, serum and pharmaceuticals using an automatic flow potentiometric system | |
CN105181844A (zh) | 一种高效液相色谱法测定甲苯磺酸索拉非尼含量和有关物质的方法 | |
CN102636582B (zh) | 测定三氮脒颗粒中三氮脒和安替比林含量的方法 | |
CN116265937A (zh) | 一种磷酸奥司他韦有关杂质的检测方法及应用 | |
CN105168224A (zh) | 一种盐酸法舒地尔注射液及其制备方法 | |
CN112710762B (zh) | 硫酸二甲酯残留量的测定方法 | |
Liu et al. | On-site solid phase extraction and HPLC determination of chloramphenicol in surface water and sewage | |
CN110763778A (zh) | 注射用泮托拉唑钠中依地酸二钠含量的分析方法 | |
CN106770749A (zh) | 一种呋喃西林生物标识物5‑硝基‑2‑糠醛的内标检测方法 | |
CN104297354A (zh) | 一种高效液相色谱法测定盐酸戊乙奎醚中杂质的检测方法 | |
CN103454355A (zh) | 一种聚丙烯酸树脂乳胶液(肠溶型)产品中单体含量的分析检测方法 | |
CN103760267B (zh) | 磷酸肌酸二钠盐含量及杂质的高效液相色谱检测方法 | |
CN104133009A (zh) | 一种用液相色谱法分析重酒石酸卡巴拉汀有关物质的方法 | |
Zhang et al. | Development and Validation of a liquid chromatography-isotope dilution tandem mass spectrometry for determination of olanzapine in human plasma and its application to bioavailability study | |
CN104359991B (zh) | 一种新的碱式依卡倍特铋有关物质的检测方法 | |
CN111175413B (zh) | 一种磺丁基倍他环糊精钠原料或其制剂中4-氯丁醇醋酸酯含量的检测方法 | |
CN111521693B (zh) | 一种单硝酸异山梨酯的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Co-patentee after: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. Patentee after: Zhuhai Yibang Pharmaceutical Co.,Ltd. Address before: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Co-patentee before: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. Patentee before: ZHUHAI EBANG PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Patentee after: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee after: National Institute for drug research (Beijing) Co.,Ltd. Address before: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Patentee before: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee before: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Kong Xiaodie Inventor after: Wu Haoshan Inventor before: Zhang Zaifu Inventor before: Wu Haoshan Inventor before: Xu Xinwen |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210204 Address after: 102629 room 409-36, 4 / F, building 1, 38 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing (cluster registration) Patentee after: Beijing aoxinda Pharmaceutical Research Institute Co.,Ltd. Address before: 519041 No.9, East jinhaian Avenue, Sanzao, Jinwan District, Zhuhai City, Guangdong Province Patentee before: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee before: National Institute for drug research (Beijing) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: AoXin sunshine (Beijing) Pharmaceutical Technology Co.,Ltd. Address before: 102629 room 409-36, 4 / F, building 1, 38 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing (cluster registration) Patentee before: Beijing aoxinda Pharmaceutical Research Institute Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: Beijing Haiyi Pharmaceutical Co.,Ltd. Address before: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee before: AoXin sunshine (Beijing) Pharmaceutical Technology Co.,Ltd. |